IP Library Granted Patent US 7,061,593
Granted Patent B2
US 7,061,593 · App. 10/219,627 · Granted Jun 13, 2006

Device and method for in vitro determination of analyte concentrations within body fluids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,061,593
App. No.
10/219,627
Granted
Jun 13, 2006
Kind
B2
Abstract

A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.

Claims (101)

1. A method for determining a concentration of an analyte in a body fluid, said method comprising:

collecting a sample of a body fluid having less than 1 μL in total volume;

holding said sample in a nonflowing manner; and

using optical transmission spectroscopy to determine said concentration, without the use of a reagent.

2. The method of claim 1 , wherein said optical transmissive spectroscopy is the measurement of energy transmitted from a source and passed through said sample.

3. The method of claim 1 , wherein said body fluid comprises saliva.

4. The method of claim 1 , wherein said body fluid comprises urine.

5. The method of claim 1 , wherein said body fluid comprises sweat.

6. The method of claim 1 , wherein said collecting further comprises using a sample extractor to create a small wound in said patient.

7. The method of claim 6 , wherein said sample extractor comprises a lance.

8. The method of claim 6 , wherein said sample extractor comprises a laser lance.

9. The method of claim 6 , wherein said sample extractor comprises an iontophoretic sampler.

10. The method of claim 6 , wherein said sample extractor comprises a gas-jet perforator.

11. The method of claim 6 , wherein said sample extractor comprises a fluid-jet perforator.

12. The method of claim 6 , wherein said sample extractor comprises a particle-jet perforator.

13. The method of claim 1 , wherein said body fluid comprises whole-blood.

14. The method of claim 1 , wherein said body fluid comprises blood components.

15. The method of claim 1 , wherein said body fluid comprises interstitial fluid.

16. The method of claim 1 , wherein said body fluid comprises intercellular fluid.

17. The method of claim 1 , wherein said sample of body fluid is 0.5 μL or less in total volume.

18. The method of claim 1 , wherein said sample of body fluid is 0.3 μL or less in total volume.

19. The method of claim 1 , wherein said collecting includes holding said sample of body fluid in at least one of a sample supply passage of a sample element and a chamber of said sample element, and said chamber is connected to said sample supply passage.

20. The method of claim 19 , wherein said sample supply passage and chamber together are configured to hold no more than 1 μL in total volume.

21. The method of claim 1 , wherein said collecting includes holding and containing said sample in a sample element that is adapted to hold no more than 1 μL of fluid.

22. A method for determining a concentration of an analyte in a body fluid, said method comprising:

collecting a sample of body fluid of 1 L or less;

filling a chamber of a sample element with at least a portion of said sample;

holding said sample within said chamber in a non-flowing manner; and

determining said concentration of said analyte in said sample using a reagentless technique.

23. The method of claim 22 , wherein said reagentless technique comprises an optical technique.

24. The method of claim 23 , wherein said optical technique comprises a spectroscopic technique.

25. The method of claim 24 , wherein said spectroscopic technique is transmissive spectroscopy.

26. The method of claim 25 , wherein said transmissive spectroscopy is the measurement of energy transmitted from a source and passed through said sample.

27. The method of claim 26 , wherein said measurement is performed on the same side of the sample as the source.

28. The method of claim 26 , wherein said measurement is performed on the opposite side of the sample in reference to the source.

29. The method of claim 22 , wherein said body fluid comprises saliva.

30. The method of claim 22 , wherein said body fluid comprises urine.

31. The method of claim 22 , wherein said body fluid comprises sweat.

32. The method of claim 22 , wherein said collecting further comprises using a sample extractor to create a small wound in said patient.

33. The method of claim 32 , wherein said sample extractor comprises a lance.

34. The method of claim 32 , wherein said sample extractor comprises a laser lance.

35. The method of claim 32 , wherein said sample extractor comprises an iontophoretic sampler.

36. The method of claim 32 , wherein said sample extractor comprises a gas-jet perforator.

37. The method of claim 32 , wherein said sample extractor comprises a fluid-jet perforator.

38. The method of claim 32 , wherein said sample extractor comprises a particle-jet perforator.

39. The method of claim 22 , wherein said body fluid comprises whole-blood.

40. The method of claim 22 , wherein said body fluid comprises blood components.

41. The method of claim 22 , wherein said body fluid comprises interstitial fluid.

42. The method of claim 22 , wherein said body fluid comprises intercellular fluid.

43. The method of claim 22 , wherein said chamber is comprised of an infrared transmissive material.

44. The method of claim 43 , wherein said infrared transmissive material is silicon.

45. The method of claim 43 , wherein said infrared transmissive material is polyethylene.

46. The method of claim 43 , wherein said infrared transmissive material is polypropylene.

47. The method of claim 43 , wherein said infrared transmissive material allows for transmission of the infrared energy having specific wavelengths.

48. The method of claim 47 , wherein said wavelengths are between 0.8 μm and 2.5 μm.

49. The method of claim 47 , wherein said wavelengths are between 2.5 μm and 20 μm.

50. The method of claim 47 , wherein said wavelengths are between 20 μm and 100 μm.

51. The method of claim 47 , wherein said wavelengths are between 3.5 μm and 14 μm.

52. The method of claim 22 , wherein said sample of body fluid is 0.5 μL or less.

53. The method of claim 22 , wherein said sample of body fluid is 0.3 μL or less.

54. The method of claim 22 , wherein said sample of body fluid is 0.1 μL or less.

55. The method of claim 22 , wherein said collecting comprises holding said sample of body fluid in at least one of a sample supply passage of said sample element and said chamber, and said sample supply passage being connected to said chamber.

56. The method of claim 55 , wherein said sample supply passage and said chamber together are configured to hold no more than 1 μL in total volume.

57. The method of claim 22 , wherein said sample element is adapted to hold no more than 1 μL in total volume of a body fluid.

58. A method for determining a concentration of an analyte in a body fluid, said method comprising:

creating an unassisted flow of said body fluid from a patient;

transporting a sample comprising 1 μL or less of said body fluid into a chamber of a sample element so that at least some of said sample is adjacent to a window of said sample element;

holding said sample in a non-flowing manner within said chamber of said sample element; and

determining said concentration of said analyte in said body fluid from said sample transported into said sample element without causing said sample to react with a reagent.

59. The method of claim 58 , wherein said collecting further comprises holding said sample element stationary while said sample enters a sample supply passage of said sample element and transports into said chamber.

60. The method of claim 58 , wherein said body fluid comprises saliva.

61. The method of claim 58 , wherein said body fluid comprises urine.

62. The method of claim 58 , wherein said body fluid comprises sweat.

63. The method of claim 58 , wherein said creating comprises using a sample extractor to create a small wound in said patient.

64. The method of claim 63 , wherein said sample extractor comprises a lance.

65. The method of claim 63 , wherein said sample extractor comprises a laser lance.

66. The method of claim 63 , wherein said sample extractor comprises an iontophoretic sampler.

67. The method of claim 63 , wherein said sample extractor comprises a gas-jet perforator.

68. The method of claim 63 , wherein said sample extractor comprises a fluid-jet perforator.

69. The method of claim 63 , wherein said sample extractor comprises a particle-jet perforator.

70. The method of claim 58 , wherein said body fluid comprises whole-blood.

71. The method of claim 58 , wherein said body fluid comprises blood components.

72. The method of claim 58 , wherein said body fluid comprises interstitial fluid.

73. The method of claim 58 , wherein said body fluid comprises intercellular fluid.

74. A method for determining a concentration of an analyte in a body fluid of an animal, said method comprising:

causing a flow of body fluid from a site on said animal using a sample extractor having an operating path near a chamber, said chamber defined by at least one inner surface, all of said at least one inner surface comprising a material which is inert with respect to said body fluid; and

collecting at least a portion of said body fluid in said chamber without displacement of said chamber, said chamber being configured to hold at most 1 μL of said body fluid.

75. The sample element of claim 74 , wherein said chamber has a volume, and said volume is inert with respect to said body fluid.

76. The method of claim 74 , wherein said causing comprises using said sample extractor to create a small wound in said animal.

77. The method of claim 76 , wherein said sample extractor comprises a lance.

78. The method of claim 76 , wherein said sample extractor comprises a laser lance.

79. The method of claim 76 , wherein said sample extractor comprises an iontophoretic sampler.

80. The method of claim 76 , wherein said sample extractor comprises a gas-jet perforator.

81. The method of claim 76 , wherein said sample extractor comprises a fluid-jet perforator.

82. The method of claim 76 , wherein said sample extractor comprises a particle-jet perforator.

83. The method of claim 74 , wherein said body fluid comprises whole-blood.

84. The method of claim 74 , wherein said body fluid comprises blood components.

85. The method of claim 74 , wherein said body fluid comprises interstitial fluid.

86. The method of claim 74 , wherein said body fluid comprises intercellular fluid.

87. The method of claim 74 , wherein said chamber is configured to hold no more than 0.5 μL of body fluid.

88. The method of claim 74 , wherein said chamber is configured to hold less than 0.3 μL of body fluid.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 11, 2017
From: HERCULES TECHNOLOGY II, L.P.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 041344/0534 →
ASSIGNMENT AND RELEASE OF SECURITY INTEREST Recorded Dec 18, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 031847/0600 →
SECURITY AGREEMENT Recorded Dec 13, 2013
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 031815/0377 →
SECURITY AGREEMENT Recorded May 23, 2008
From: OPTISCAN BIOMEDICAL CORPORATION
To: HERCULES TECHNOLOGY II, L.P.
Reel/Frame 020995/0202 →
CHANGE OF NAME Recorded Jun 23, 2006
From: LING DYNAMIC SYSTEMS, INC.
To: LDS TEST AND MEASUREMENT INC.
Reel/Frame 017833/0357 →
PATENT COLLATERAL ASSIGNMENT Recorded Jun 22, 2005
From: OPTISCAN BIOMEDICAL CORPORATION
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 016172/0354 →